How cancer patients relying on daratumumab feel physically before starting the therapy can predict how long they will live and how well they will respond to the anti-multiple myeloma (MM ...

Pieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, discussed the continued use of subcutaneous daratumumab following initial ...

How cancer patients relying on daratumumab feel physically before starting the therapy can predict how long they will live and how well they will respond to the anti- multiple myeloma (MM ...

How cancer patients feel physically before beginning treatment with daratumumab can predict how long they will live and how well they will respond to this multiple myeloma therapy, according to ...

This novel predictor is designed to identify multiple myeloma patients most likely to benefit from daratumumab. The daratumumab DRP ® was developed by correlating gene expression patterns with ...

This novel predictor is designed to identify multiple myeloma patients most likely to benefit from daratumumab. The daratumumab DRP ® was developed by correlating gene expression patterns with ...

These first-person essays are part of a special series leading up to the 109th running of the Indianapolis 500 on May 25 on FOX in which INDYCAR drivers penned letters about what the historic race ...

The MAIA study showed significant survival benefits for older, transplant-ineligible patients using daratumumab, lenalidomide, and dexamethasone (DRd). Quadruple therapy is being explored ...

Vanguard's S&P 500 ETF is a great way to diversify your investments. The S&P 500 has seen a historical average annual return of about 10%. The recent market turmoil is a good reminder that you ...